Introduced
by
To require annual reports from pharmaceutical makers and distributors that disclose the value, nature, and purpose of any research and development expenditures made by the company. The bill also authorizes imposing fees on the companies for the cost of the Department of Community Heath collecting and filing these reports.
Referred to the Committee on Health Policy
